Winton Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-15,489
| Closed | -$880K | – | 1121 |
|
|
2021
Q3 | $880K | Sell |
15,489
-2,602
| -14% | -$148K | 0.05% | 568 |
|
|
2021
Q2 | $796K | Sell |
18,091
-1,633
| -8% | -$71.9K | 0.04% | 654 |
|
|
2021
Q1 | $973K | Buy |
19,724
+358
| +2% | +$17.7K | 0.06% | 476 |
|
|
2020
Q4 | $815K | Sell |
19,366
-24,536
| -56% | -$1.03M | 0.06% | 515 |
|
|
2020
Q3 | $2.01M | Sell |
43,902
-67,867
| -61% | -$3.11M | 0.07% | 525 |
|
|
2020
Q2 | $5.61M | Sell |
111,769
-13,703
| -11% | -$688K | 0.14% | 173 |
|
|
2020
Q1 | $6.45M | Sell |
125,472
-12,508
| -9% | -$643K | 0.17% | 163 |
|
|
2019
Q4 | $8.52M | Buy |
137,980
+134,298
| +3,647% | +$8.3M | 0.12% | 290 |
|
|
2019
Q3 | $221K | Sell |
3,682
-2,413
| -40% | -$145K | ﹤0.01% | 1369 |
|
|
2019
Q2 | $514K | Buy |
6,095
+1,539
| +34% | +$130K | 0.01% | 674 |
|
|
2019
Q1 | $435K | Buy |
4,556
+1,054
| +30% | +$101K | 0.01% | 639 |
|
|
2018
Q4 | $248K | Sell |
3,502
-1,175
| -25% | -$83.2K | 0.01% | 730 |
|
|
2018
Q3 | $400K | Sell |
4,677
-37,330
| -89% | -$3.19M | 0.01% | 713 |
|
|
2018
Q2 | $4.87M | Buy |
42,007
+37,231
| +780% | +$4.32M | 0.12% | 285 |
|
|
2018
Q1 | $386K | Buy |
+4,776
| New | +$386K | 0.01% | 882 |
|